Join to View Full Profile
11100 Euclid Ave - Lakeside 1200 Mailstop 5079Cleveland, OH 44106
Phone+1 216-262-1214
Dr. Barata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pedro Barata is a genitourinary oncologist in Cleveland, Ohio and is affiliated with Case Western Reserve University.
Education & Training
University of Lisbon Faculty of MedicineClass of 2009
Certifications & Licensure
OH State Medical License 2022 - 2026
LA State Medical License 2018 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combining EPI-7386 with Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer Start of enrollment: 2024 May 16
- Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study Start of enrollment: 2022 Dec 01
- International Registry for Men With Advanced Prostate Cancer (IRONMAN) Start of enrollment: 2017 Jul 21
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsNatural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada
Prostate Cancer and Prostatic Diseases. 2025-03-01 - STELLAR-304: a phase III study of zanzalintinib (XL092) plus nivolumab in advanced non-clear cell renal cell carcinoma.Sumanta K Pal, Thomas Powles, Ravindran Kanesvaran, Javier Molina-Cerrillo, Darren R Feldman
Future Oncology. 2025-03-01 - Implementing and Optimizing Universal Germline Genetic Testing for Patients With Prostate Cancer in Clinical Practice.Neal Shore, Andrew J Armstrong, Pedro Barata, Lindsey Byrne, Jason Hafron
Urology. 2025-02-03
Journal Articles
- Treatment Selection for Men with Metastatic Prostate Cancer Who Progress on Upfront Chemo‐Hormonal TherapyVadim Koshkin, Prateek Mendiratta, Brian I Rini, Pedro Barata, Christos Kyriakopoulos, Hamid Emamekhoo, Timothy Gilligan, The Prostate
Press Mentions
Physicians Ignore Recommendations for Prostate Cancer Treatment, Study SuggestsMarch 18th, 2025- Advancing RCC Treatment: Biomarkers, Combination Therapies, and Emerging InnovationsJanuary 8th, 2025
- 3 Innovations That Help Detect Killer Cancers EarlierMay 17th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
